Modern Rheumatology
Volume 30, 2020 - Issue 1
Open access
4,575
Views
34
CrossRef citations to date
0
Altmetric
Original Articles: Rheumatoid Arthritis
Safety profile of baricitinib in Japanese patients with active rheumatoid arthritis with over 1.6 years median time in treatment: An integrated analysis of Phases 2 and 3 trials
Masayoshi HarigaiDivision of Epidemiology and Pharmacoepidemiology of Rheumatic Diseases, Department of Rheumatology, School of Medicine, Tokyo Women's Medical University, Tokyo, Japan; View further author information
, Tsutomu TakeuchiDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan; View further author information
, Josef S. SmolenDivision of Rheumatology, Department of Medicine, Medical University of Vienna, Vienna, Austria; View further author information
, Kevin L. WinthropDepartment of Medicine & Ophthalmology, Oregon Health & Science University, Portland, OR, USA; View further author information
, Atsushi NishikawaMedicines Development Unit, Eli Lilly Japan K.K., Kobe, Japan; View further author information
, Terence P. RooneyLilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA; View further author information
, Chadi G. SaifanLilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA; View further author information
, Maher IssaLilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA; View further author information
, Yoshitaka IsakaMedicines Development Unit, Eli Lilly Japan K.K., Kobe, Japan; View further author information
, Naotsugu AkashiMedicines Development Unit, Eli Lilly Japan K.K., Kobe, Japan; Correspondence[email protected]
View further author information
, View further author information
Taeko IshiiMedicines Development Unit, Eli Lilly Japan K.K., Kobe, Japan; View further author information
& Yoshiya TanakaFirst Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, JapanView further author information
show all
Pages 36-43
|
Received 20 Dec 2018, Accepted 25 Jan 2019, Published online: 21 Mar 2019
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.